The growing Urbanization and Change in Lifestyle of the people along with mergers and acquisition activities by the key players in this region is propelling the growth of Crohn’s disease market in this region

North America is anticipated to grow with a significant CAGR in the forecasted period. This is attributed towards changes in the lifestyle of the people, such as changes in diet, smoking, alcohol consumption and exposure to industrial chemicals environment in this region. Additionally, the mergers and acquisition activities in this region by the key market players are also attributed towards the market growth. For Instance, in January 2022, Crohn’s & Colitis Foundation enters a partnership with LifeArc to develop the first clinical tests to predict disease course and response to treatment in pediatric Crohn’s patients. Furthermore, the increasing prevalence of Crohn’s disease has led to increase in demand for pre-diagnostics in this region.

Access sample report (including graphs, charts, and figures) – https://univdatos.com/get-a-free-sample-form-php/?product_id=45716

North America Crohn’s Disease Market Revenue (2020-2028) – USD Mn

Based on diagnostics, the market is segmented into blood tests, faecal tests, colonoscopies, flexible sigmoidoscopy, computerized tomography, magnetic resonance imaging and others. Amongst these, the computerized tomography segment is anticipated to grow with a significant CAGR in the forecast period.

Based on the treatment, the market is bifurcated into medication and surgery. Amongst these, the surgical segment is anticipated to grow with a significant CAGR in the forecasted period.

For a detailed analysis of the Global Crohn’s Disease Market browse through – https://univdatos.com/report/crohns-disease-market/

Global Crohn’s Disease Market Segmentation

Market Insight, by Diagnostics

· Blood Test

· Faecal Test

· Colonoscopy

· Flexible Sigmoidoscopy

· Computerized Tomography

· Magnetic Resonance Imaging

· Others

Market Insights, by Treatment

· Medication

· Surgery

Market Insight, by Region

· North America

o U.S.

o Canada

o Rest of North America

· Europe

o UK

o Germany

o France

o Italy

o Spain

o Rest of Europe

· APAC

o China

o Japan

o India

o South Korea

o Rest of APAC

· Rest of the World

Top Company Profiles

· Takeda Pharmaceutical Company Limited.

· Janssen Global Services, LLC,

· UCB S.A.,

· Biogen

· AbbVie Inc.

· Genentech, Inc.

· Gilead Sciences, Inc.

· Eli Lilly and Company

· Pfizer Inc.

· Johnson & Johnson Services, Inc.